WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[WuXi PharmaTech (Cayman) Inc. Form 6-K Disclosure Charles River WuXi Antitrust Division FTC HSR Act Transaction As previously disclosed, both Charles River Laboratories International, Inc. ( second request On July 12, 2010, WuXi received a Request for Additional Information (commonly referred to as a Completion of the Transaction remains subject to the approval of both Charles River and WuXi]